The crystal structure of N′-(2-chloro-6-hydroxybenzylidene)thiophene-2-carbohydrazide monohydrate, C12H11ClN2O3S

C12H11ClN2O3S, monoclinic, P21/n (no. 14), a = 4.7305(8) Å, b = 21.252(4) Å, c = 13.134(2) Å, β = 96.286(2)°, Z = 4, V = 1312.5(4) Å3, R gt (F) = 0.1002, wR ref (F 2) = 0.1118, T = 296 K.

Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-phenylfuran, C22H21BrO2

C21H21BrO2, monoclinic, P21/c (no. 14), a = 22.175(2) Å, b = 5.8375(6) Å, c = 14.8729(14) Å, β = 100.936(1)°, V = 1890.3(3) Å3, Z = 4, R gt (F) = 0.0343, wR ref(F 2) = 0.0839, T = 296(2) K.

The crystal structure of 1-(2-bromoethane)-4-amine-3,5-dinitropyrazole, C5H6Br1N5O4

C5H6Br1N5O4, orthorhombic, Pbca (no. 61), a = 11.4370(4) Å, b = 6.9921(2) Å, c = 22.8443(9) Å, β = 90°, V = 1826.83(11) Å3, Z = 8, R gt (F) = 0.0357, wR ref (F 2) = 0.1062, T = 100 K.

The crystal structure of poly[diaqua-(μ2-1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ2N:N′)-bis(μ3-terephthalato-κ3O:O′:O′′)dicadmium(II)], C17H15N6O5Cd

C17H15N6O5Cd, monoclinic, P21/c (no. 14), a = 10.095(2) Å, b = 13.380(3) Å, c = 14.968(5) Å, β = 115.16(2)°, V = 1829.9(9) Å3, Z = 4, R gt (F) = 0.0267, wR ref (F 2) = 0.0602, T = 293(2) K.

Halogen bonds in the crystal structure of 4,3′:5′,4″-terpyridine — 1,3-diiodotetrafluorobenzene (1/1), C21H11F4I2N3

C21H11F4I2N3, orthorhombic, Pnma (no. 62), a = 11.0042(4) Å, b = 20.6209(5) Å, c = 9.2371(3) Å, V = 2096.05(11) Å3, Z = 4, R gt (F) = 0.0316, wR ref (F 2) = 0.0556, T = 293(2) K.

Chalcogen bonds in the crystal structure of 4,7-dibromo-2,1,3-benzoselenadiazole, C6H2Br2N2Se

C6H2Br2N2Se, monoclinic, P21/c (no. 14), a = 7.7277(4) Å, b = 19.6360(6) Å, c = 10.8656(5) Å, β = 102.124(4)°, V = 1611.98(12) Å3, Z = 4, R gt (F) = 0.0482, wR ref (F 2) = 0.1175, T = 290 K.

Crystal structure of (μ4-(1,2,4,5-tetra(1,2,4-triazol-1-ylmethyl)-benzene-κ4 N:N1:N2:N3 )disilver(I) diperchlorate

C9H9N6O4ClAg, monoclinic, C2/c (no. 15), a = 24.730(5) Å, b = 11.776(2) Å, c = 9.6860(19) Å, β = 109.09(3)°, V = 2665.6(9) Å3, Z = 8, R gt (F) = 0.0646, wR ref (F 2) = 0.2177, T = 293(2) K.

Crystal structure of (4′E)-6′-(diethylamino)-2-[(E)-[(pyren-1-yl)methylidene]amino]-4′-{2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]ethylidene}-1′,2,2′,3,3′,4′-hexahydrospiro[isoindole-1,9′-xanthene]-3-one, C54H48N4O2

C54H48N4O2, triclinic, P 1 ‾ $P‾{1}$ (no. 2), a = 11.1883(5) Å, b = 13.5364(5) Å, c = 14.3412(5) Å, α = 105.885(3)°, β = 97.710(3)°, γ = 94.126(3)°, Z = 2, V = 2056.64(14) Å3, R gt (F) = 0.0685, wR ref (F 2) = 0.1606, T = 293(2) K.

Crystal structure of (E)-N′-(1-(2-hydroxy-4-methoxyphenyl)ethylidene) isonicotinohydrazide, C15H15N3O3

C15H15N3O3, triclinic, P 1 ‾ $\overline{1}$ (no. 2), a = 9.0752(2) Å, b = 9.1969(2) Å, c = 9.9519(2) Å, α = 112.7059(8)°, β = 92.4309(8)°, γ = 115.2776(7)°, V = 671.16(3) Å3, Z = 2, R gt (F) = 0.0347, wR ref (F 2) = 0.1113, T = 100 K.